NHS ENGLAND
Buyer information published with procurement notices.
- Published identifier
- GB-PPON PDPT-3135-BWWY
- Address
- London, UKI45, SE1 8UG, United Kingdom
- First notice
- 30 Jan 2025
- Latest notice
- 22 Oct 2026
Published procurement activity · 1,388 tenders
Buyer information published with procurement notices.
NHS England has awarded a contract to a competent and capable supplier to host the NHS Race and Health Observatory (NHS RHO).<br/>The appointed Host Supplier will support the delivery of an agreed programme of works that will bridge the gap in the stark race and ethnic health inequalities across the healthcare system.
The requirement is for outcomes-based deliverables to scope, design and build the appropriate data access and extraction and transfer to NHSE via the NHS Cyber API, as structured Measures, Metrics & Indicators, into the NHS Cyber Data Platform.
NHS England is looking to the market to comment on a draft specification for the Future of patient feedback and also understand the capacity and capability of the market to understand how this potential opportunity may be procured. We are asking potential providers to complete the Request for Information document included within
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025<br/>CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 <br/>CM/PHR/24/5680/02 - Eculizumab and Ravulizu
Education & Training contract with Keele University<br/><br/> https://atamis-1928.my.salesforce.com/sfc/p/0O000000rwim/a/Sr0000012G89/wn7njEyE0Nhi_VJrDnU58Qszr4D8vUdqGhlhlchR18k
An agreement with Academy of Healthcare Science to provide coaching and trauma leadership training to audiology staff in hearing services across England. This includes sessions on giving compassionate news to staff and patients and self-care as a consequence of difficult conversations.
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025<br/>CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines – Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027<br/>CM/PHR/
NHS England is undertaking a review of the current processes and commercial models which support the prescribing/supply of Stoma and Continence products listed on Part IX of the NHS Drug Tariff and is requesting feedback and information on current arrangements to help inform the future strategy in these categories. If not alread
NHS England is looking to engage with suppliers who can delivery psychological support and counselling services for resident doctors. It is an NHSE requirement for postgraduate deaneries to provide counselling and wellbeing services to resident doctors and dentists. Counselling and wellbeing support is critical for reducing post
The Voluntary Community and Social Enterprise (VCSE) sector is a vital partner of NHS England, offering expertise and informing policy, programmes and improving service delivery across its teams and directorates. NHS England (NHSE) is issuing this Invitation to Quote (ITQ) to establish a single contractual arrangement with a nat
Organisation details and tender classifications reflect information published by the original procurement sources. Similar buyer names are grouped only where an official identifier or compatible name and postcode provide a safe link.